The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Abstract
Here we used mice lacking tumor necrosis factor-alpha (TNF alpha) and its associated receptors to study a model of demyelination and remyelination in which these events could be carefully controlled using a toxin, cuprizone. Unexpectedly, the lack of TNF alpha led to a significant delay in remyelination as assessed by histology, immunohistochemistry for myelin proteins and electron microscopy coupled with morphometric analysis. Failure of repair correlated with a reduction in the pool of proliferating oligodendrocyte progenitors (bromodeoxyuridine-labeled NG2(+) cells) followed by a reduction in the number of mature oligodendrocytes. Analysis of mice lacking TNF receptor 1 (TNFR1) or TNFR2 indicated that TNFR2, not TNFR1, is critical to oligodendrocyte regeneration. This unexpected reparative role for TNF alpha in the CNS is important for understanding oligodendrocyte regeneration/proliferation, nerve remyelination and the design of new therapeutics for demyelinating diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This aligns with the notion that the debris-clearing function of myeloid cells and mediators released from innate immune cells stimulate remyelination.61-63”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [61]
In the citing paper
“We found SJL mice demyelinate partially at midline (Figure 2A), whereas C57BL/6 mice show robust demyelination, particularly at week 5 2, 23, 35.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [2]
In the citing paper
“C57BL/6 mice showed greater than 50% remyelination within 2 weeks of discontinuation of cuprizone 2, 42, which is in stark contrast to the reduced remyelination reported here for SJL.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [2]
In the citing paper
“The increased severity in EAE may be because of T‐cell immune mechanisms that are not induced by cuprizone intoxication 2, 24.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [2]
In the citing paper
“Thus, unlike microglia and astrocytes in C57BL/6 mice that respond vigorously to demyelination 2, 23, 39, these cell types in SJL mice have a guarded response at midline and in the lateral region, which correlates with subdued demyelination.”
From SJL Mice Exposed to Cuprizone Intoxication Reveal Strain and Gender Pattern Differences in Demyelination (2009) · cites this paper as [2]
In the citing paper
“TNF expression levels are increased after one week of cuprizone-induced demyelination in vivo [224] and TNFα−/− mice showed a delay in demyelination in the cuprizone model [56], consistent with a role for TNF to exacerbate cuprizone-induced demyelination.”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [224]
In the citing paper
“However, TNF is also required for remyelination [224].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [224]
In the citing paper
“Overall, cuprizone-induced de- and remyelination are not mediated by B or T cells, as shown by the use of RAG −/− mice that lack lymphocytes (Arnett et al., 2001; Hiremath et al., 2008).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
In the citing paper
“In the cuprizone model, TNF-α was demonstrated to act as well in a bivalent manner since TNF-α −/− mice displayed a reduced loss of oligodendrocytes during the first 3.5 weeks of cuprizone feeding but also a significantly diminished ability to remyelinate (Arnett et al., 2001).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
In the citing paper
“Furthermore, similar to TNF-α-deficient mice TNFR2 −/− mice displayed diminished/delayed regeneration of myelin”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
In the citing paper
“In this study TNFR2 but not TNFR1 has been shown to be gradually up-regulated during de- and remyelination (Arnett et al., 2001).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
In the citing paper
“However, a growing body of evidence corroborates the assumption that an adequate and controlled inflammatory response is required for a successful myelin regeneration promoting the clearance of myelin debris and stimulating proliferation/regeneration of myelin-forming oligodendrocytes (Diemel et al., 1998; Robinson and Miller, 1999; Arnett et al., 2001; Kotter et al., 2001, 2005, 2006; Setzu et al”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
In the citing paper
“suggesting that beneficial effects of TNF-α on proliferation of OPC and subsequent remyelination are promoted through the TNFR2 pathway (Arnett et al., 2001).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Arnett et al., 2001
In the citing paper
“Functional studies using recombinase activating gene-1 knockout (RAG-1 -/-) mice suggest that the recruited CD3 + lymphocytes do not play a major role during cuprizone-induced demyelination and the subsequent endogenous remyelination process (Arnett et al., 2001;Bieber et al., 2003;Hiremath et al., 2008).”
From Cuprizone‐induced demyelination triggers a CD8‐pronounced T cell recruitment (2021) · cites this paper as Arnett et al., 2001
In the citing paper
“Such cytokines can thus be harmful for the cerebral elements (138) but they also play beneficial roles in the inflammatory response (161–163).”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [161]
Citations
Cites
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,281
Pasparakis, M., Alexopoulou, L., Episkopou, V., & Kollias, G. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,068
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984
Self-citationIdentification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 891
Characterization of tumor necrosis factor-deficient mice
Marino, M. W., Dunn, A. R., Grail, D., Inglese, M., Noguchi, Y., Richards, E. A., Jungbluth, A., Wada, H., Moore, M. A. S., Williamson, B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8093 · Cited by 767
Self-citationvan Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J., Bertelsmann, F. W., Blomberg, B. M. E. V., Woody, J. N., Hartung, H., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 735
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.4.1193 · Cited by 689
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
Offner, H., Zamora, A., Drought, H., Matejuk, A., Auci, D. L., Morgan, E. E., Vandenbark, A. A., & Reading, C. L. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00214-x · Cited by 40
Cuprizone‐induced demyelination triggers a CD8‐pronounced T cell recruitment
Kaddatz, H., Joost, S., Nedelcu, J., Chrzanowski, U., Schmitz, C., Gingele, S., Gudi, V., Stangel, M., Zhan, J., Santrau, E., et al. (2021) · Glia · doi:10.1002/glia.23937 · Cited by 39
“ation and the subsequent endogenous remyelination process (Arnett et al., 2001; Bieber et al., 2003; Hiremath et al., 2008).”
BackgroundTitomanlio, L., Fernández‐López, D., Manganozzi, L., Moretti, R., Vexler, Z. S., & Gressèns, P. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.01.016 · Cited by 42
Poly(I:C) promotes TNFα/TNFR1-dependent oligodendrocyte death in mixed glial cultures
Steelman, A. J., & Li, J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-89 · Cited by 39
Iron Availability Compromises Not Only Oligodendrocytes But Also Astrocytes and Microglial Cells
Rosato‐Siri, M. V., Marziali, L. N., Guitart, M. E., Badaracco, M. E., Puntel, M., Pitossi, F. J., Correale, J. D., & Pasquini, J. M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0369-2 · Cited by 39
Fischer, R., Padutsch, T., Bracchi-Ricard, V. C., Murphy, K., Martinez, G. F., Delguercio, N., Elmer, N. A., Sendetski, M., Diem, R., Eisel, U. L. M., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.021 · Cited by 39
Induction of endogenous neural precursors in mouse models of spinal cord injury and disease
Azari, M. F., Profyris, C., Zang, D., Petratos, S., & Cheema, S. S. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01066.x · Cited by 39
Ye, P., Kollias, G. A., & D’Ercole, A. J. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21181 · Cited by 39
A silver lining of neuroinflammation: Beneficial effects on myelination
Goldstein, E. Z., Church, J. S., Hesp, Z. C., Popovich, P. G., & McTigue, D. M. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.001 · Cited by 41
Rinaldi, M., Thomas, L., Mathieu, P., Carabias, P., Troncoso, M. F., Pasquini, J. M., Rabinovich, G. A., & Pasquini, L. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.003 · Cited by 38
Stafford, C. A., Lawlor, K. E., Heim, V. J., Bankovacki, A., Bernardini, J. P., Silke, J., & Nachbur, U. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.024 · Cited by 38
Unal, D. B., Caliari, S. R., & Lampe, K. J. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c01164 · Cited by 38
Raffaele, S., & Fumagalli, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.950819 · Cited by 40
Glia Connect Inflammation and Neurodegeneration in Multiple Sclerosis
Sun, Y., Yu, H., & Guan, Y. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01034-9 · Cited by 38
Perinatal Brain Damage Causation
Dammann, O., & Leviton, A. (2007) · Developmental Neuroscience · doi:10.1159/000105469 · Cited by 38
Sun, F., Lin, C. G., Mctigue, D., Shan, X., Tovar, C. A., Bresnahan, J. C., & Beattie, M. S. (2010) · Glia · doi:10.1002/glia.21009 · Cited by 38
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Alkhawajah, M. M., Caminero, A. B., Freeman, H. J., & Oger, J. J.-F. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512461393 · Cited by 38
Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis
Hatch, M. N., Schaumburg, C. S., Lane, T. E., & Keirstead, H. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.05.002 · Cited by 38
Remyelination and Restoration of Axonal Function by Glial Cell Transplantation
Duncan, I. D. (2006) · Springer eBooks · doi:10.1007/3-540-27626-2_7 · Cited by 38
Siebert, J. R., Eade, A. M., & Osterhout, D. J. (2015) · BioMed Research International · doi:10.1155/2015/752572 · Cited by 40
Zheng, Z., Jiang, H., Huang, Y., Wang, J., Qiu, L., Hu, Z., Ma, X., & Lu, Y. (2016) · Scientific Reports · doi:10.1038/srep25672 · Cited by 37
Hossain, M. J., Tănăsescu, R., & Gran, B. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.12.004 · Cited by 37
McCarthy, C. A., Widdop, R. E., Deliyanti, D., & Wilkinson‐Berka, J. L. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12099 · Cited by 36
Li, T., Giaume, C., & Xiao, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8625-1 · Cited by 38
Modeling conduction delays in the corpus callosum using MRI-measured g-ratio
Berman, S., Filo, S., & Mezer, A. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2019.03.025 · Cited by 36
Uesugi, M., Nakajima, K., Tohyama, Y., Kohsaka, S., & Kurihara, T. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.043 · Cited by 36
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis
Theophanous, S., Sargiannidou, I., & Kleopa, K. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179588 · Cited by 38
Shobeiri, P., Seyedmirzaei, H., Karimi, N., Rashidi, F., Teixeira, A. L., Brand, S., Bahmani, D. S., & Rezaei, N. (2022) · European journal of medical research · doi:10.1186/s40001-022-00814-9 · Cited by 35
Hu, Y. N., Xiao, H., Shi, T., Oppenheim, J. J., & Chen, X. (2014) · Immunology · doi:10.1111/imm.12241 · Cited by 35
Antagonists of TNF action: clinical experience and new developments
Kontermann, R. E., Scheurich, P., & Pfizenmaier, K. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902785167 · Cited by 35
Vigilance or Subversion? Constitutive and Inducible M Cells in Mucosal Tissues
Lo, D. D. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.09.002 · Cited by 34
Han, S. R., Kang, Y. H., Jeon, H., Lee, S., Park, S., Song, D., Min, S. S., Min, S. S., Lee, M., & Lee, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020646 · Cited by 37
Ansari, M. A., Nadeem, A., Alshammari, M. A., Attia, S. M., Bakheet, S. A., Khan, M. R., Albekairi, T. H., Alasmari, A. F., Alhosaini, K. A., Alqahtani, F., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.113997 · Cited by 35
Zveik, O., Fainstein, N., Rechtman, A., Haham, N., Ganz, T., Lavon, I., Brill, L., & Vaknin‐Dembinsky, A. (2022) · Glia · doi:10.1002/glia.24165 · Cited by 35
Rajasundaram, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00402 · Cited by 37
Neural stem cells in inflammatory CNS diseases: mechanisms and therapy
Magnus, T., & Rao, M. S. R. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00357.x · Cited by 34
Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
Fiedler, T., Fairless, R., Pichi, K., Fischer, R., Richter, F., Kontermann, R. E., Pfizenmaier, K., Diem, R., & Williams, S. K. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02784-z · Cited by 33
Astrocyte-Derived Pleiotrophin Mitigates Late-Stage Autoimmune CNS Inflammation
Linnerbauer, M., Lößlein, L., Farrenkopf, D., Vandrey, O., Tsaktanis, T., Naumann, U., & Rothhammer, V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.800128 · Cited by 33
Shang, X., Wang, B., Sun, Q., Zhang, Y., Lu, Y., Liu, S., & Li, Y. (2022) · Fish Physiology and Biochemistry · doi:10.1007/s10695-022-01046-8 · Cited by 33
CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model
Ingersoll, S. A., Martin, C. B., Barnum, S. R., & Martin, B. K. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.08.007 · Cited by 33
Prospects of repair in multiple sclerosis
Yong, V. W. (2009) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(09)70006-1 · Cited by 33
Wheeler, R. D., Zehntner, S. P., Kelly, L. M., Bourbonnière, L., & Owens, T. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02395.x · Cited by 34
Yarahmadi, A., Zare, M. A., Aghayari, M., Afkhami, H., & Jafari, G. A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01622-w · Cited by 32
Mahil, S. K., Andrews, T., Brierley, C. K., Barker, J. N., & Smith, C. H. (2012) · Journal of Dermatological Treatment · doi:10.3109/09546634.2012.660520 · Cited by 32
Cellular senescence and failure of myelin repair in multiple sclerosis
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111366 · Cited by 33
Stimulation of Adult Oligodendrogenesis by Myelin-Specific T Cells
Nielsen, H. H., Toft‐Hansen, H., Lambertsen, K. L., Owens, T., & Finsen, B. R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.006 · Cited by 35
Gene network underlying the glial regenerative response to central nervous system injury
Kato, K., Losada‐Pérez, M., & Hidalgo, A. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24565 · Cited by 34
van Marle, G., Antony, J. M., Silva, C., Sullivan, A., & Power, C. (2005) · AIDS · doi:10.1097/01.aids.0000189854.06194.87 · Cited by 32
Praet, J., Orije, J. E. M. J., Kara, F., Guglielmetti, C., Santermans, E., Daans, J., Hens, N., Verhoye, M., Berneman, Z. N., Ponsaerts, P., et al. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3277 · Cited by 32
Role of inflammation in the neurobiology of stem cells
Simard, A. R., & Rivest, S. (2004) · Neuroreport · doi:10.1097/00001756-200410250-00001 · Cited by 31
Schneider, R., Koop, B. E., Schröter, F., Cline, J. E., Ingwersen, J., Berndt, C., Hartung, H., Aktaş, O., & Prozorovski, T. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0117-0 · Cited by 32
The crucial role of Erk2 in demyelinating inflammation in the central nervous system
Okazaki, R., Doi, T., Hayakawa, K., Morioka, K., Imamura, O., Takishima, K., Hamanoue, M., Sawada, Y., Nagao, M., Tanaka, S., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0690-8 · Cited by 31
Iocca, H. A., Plant, S. R., Wang, Y., Runkel, L., O’Connor, B. P., Lundsmith, E. T., Hahm, K., van Deventer, H. W., Burkly, L. C., & Ting, J. P. ‐. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.12.003 · Cited by 31
Self-citationBonetto, G., Charalampopoulos, I., Gravanis, A., & Karagogeos, D. (2017) · Glia · doi:10.1002/glia.23170 · Cited by 33
Cytokines in CNS Inflammation and Disease
Tansey, M. G., & Wyss‐Coray, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_5 · Cited by 32
Schmidt, H., Raasch, J., Merkler, D., Klinker, F., Krauss, S., Brück, W., & Prinz, M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.002 · Cited by 31
Mazziotti, V., Crescenzo, F., Turano, E., Guandalini, M., Bertolazzo, M., Ziccardi, S., Virla, F., Camera, V., Marastoni, D., Tamanti, A., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03193-6 · Cited by 31
Targeting tumour necrosis factor to ameliorate viral pneumonia
Pandey, P., & Karupiah, G. (2021) · FEBS Journal · doi:10.1111/febs.15782 · Cited by 30
Chew, L., & DeBoy, C. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.06.008 · Cited by 32
Interleukin-6 and type 1 interferons inhibit varicella zoster virus replication in human neurons
Como, C. N., Pearce, C. M., Cohrs, R. J., & Baird, N. L. (2018) · Virology · doi:10.1016/j.virol.2018.06.013 · Cited by 30
Do pathogen exposure and innate immunity cause brain diseases?
Simard, A. R., & Rivest, S. (2005) · Neurological Research · doi:10.1179/016164105x49526 · Cited by 30
Wylot, B., Mieczkowski, J., Niedziolka, S., Kaminska, B., & Zawadzka, M. (2019) · Cells · doi:10.3390/cells9010099 · Cited by 29
Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis
Navarrete, C. M., García‐Martín, A., Garrido‐Rodríguez, M., Mestre, L., Feliú, A., Guaza, C., Calzado, M. A., & Muñóz, E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104994 · Cited by 29
Wei, X., Li, X., Liu, P., Li, L., Chen, H., Li, D., Liu, J., & Xie, L. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160265 · Cited by 29
Macrophage–Neuroglia Interactions in Promoting Neuronal Regeneration in Zebrafish
Zeng, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076483 · Cited by 29
Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease
Alexandre, B., Vandermeeren, Y., Dewit, O., Moreels, T. G., de Boer, N. K. H., Dhar, A., Ziady, C., Shitrit, A. B., Steinwurz, F., Jojic, N., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw003 · Cited by 29
Diemel, L. T., Wolswijk, G., Jackson, S. J., & Cuzner, M. L. (2003) · Glia · doi:10.1002/glia.10335 · Cited by 29
Glial Cell Dynamics in Neuroinflammation: Mechanisms, Interactions, and Therapeutic Implications
García‐Domínguez, M. (2026) · Biomedicines · doi:10.3390/biomedicines14010115 · Cited by 32
Wang, N., Huang, Y., Li, A., Jiang, H., Wang, J., Li, J., Qiu, L., Li, K., & Lu, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111940 · Cited by 28
Dukay, B., Walter, F. R., Vigh, J. P., Barabási, B., Hajdu, P., Balassa, T., Migh, E., Kincses, A., Hoyk, Z., Szögi, T., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02070-2 · Cited by 30
Cabilly, Y., Barbi, M., Geva, M., Marom, L., Chetrit, D., Ehrlich, M., & Elroy‐Stein, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046715 · Cited by 28
Paez, P. M., Cheli, V. T., Ghiani, C. A., Spreuer, V., Handley, V., & Campagnoni, A. T. (2012) · Glia · doi:10.1002/glia.22336 · Cited by 30
Axonal degeneration stimulates the formation of NG2+ cells and oligodendrocytes in the mouse
Nielsen, H. H., Ladeby, R., Drøjdahl, N., Peterson, A. C., & Finsen, B. R. (2006) · Glia · doi:10.1002/glia.20357 · Cited by 28
Schmidt, J., Metselaar, J. M., & Gold, R. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100915 · Cited by 28
A cord blood monocyte–derived cell therapy product accelerates brain remyelination
Saha, A., Buntz, S., Scotland, P., Xu, L., Noeldner, P. K., Patel, S. A., Wollish, A., Gunaratne, A., Gentry, T., Troy, J. D., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86667 · Cited by 28
Self-citationTumour Necrosis Factor in Neuroplasticity, Neurogenesis and Alcohol Use Disorder
Cooper, I. A., Beecher, K., Chehrehasa, F., Belmer, A., & Bartlett, S. E. (2020) · Brain Plasticity · doi:10.3233/bpl-190095 · Cited by 31
Arnett, H. A., & VINEY, J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.013 · Cited by 27
Self-citationMagliozzi, R., Pezzini, F., Pucci, M., Rossi, S., Facchiano, F., Marastoni, D., Montagnana, M., Lippi, G., Reynolds, R., & Calabrese, M. (2021) · Cells · doi:10.3390/cells10071712 · Cited by 27
Lentiviral vectors for gene delivery to normal and demyelinated white matter
Zhao, C., Strappe, P., Lever, A. M. L., & Franklin, R. J. M. (2003) · Glia · doi:10.1002/glia.10195 · Cited by 27
Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5
Behrangi, N., Heinig, L., Frintrop, L., Santrau, E., Kurth, J., Krause, B., Atanasova, D., Clarner, T., Fragoulis, A., Joksch, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204509119 · Cited by 27
Khoja, S., Liu, X.-B., Truong, B., Nitzahn, M., Lambert, J., Eliav, A., Nasser, E., Randolph, E., Burke, K. E., White, R. A., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.012 · Cited by 26
Bibliometric analysis of tumor necrosis factor in post-stroke neuroinflammation from 2003 to 2021
Zhao, Y., Zhu, Q., Bi, C., Yuan, J., Chen, Y., & Xiao-fei, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1040686 · Cited by 26
Filipovic, R., & Zečević, N. (2004) · Glia · doi:10.1002/glia.20125 · Cited by 26
Lim, S. (2010) · The Open Autoimmunity Journal · doi:10.2174/1876894601002040160 · Cited by 26
Cannabinoids in Microglia: A New Trick for Immune Surveillance and Neuroprotection
Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.004 · Cited by 26
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies
Kotelnikova, E. A., Bernardo-Faura, M., Silberberg, G., Kiani, N. A., Messinis, D. E., Melas, I. N., Artigas, L., Schwartz, E., Mazo, I. A., Masso, M., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514543339 · Cited by 26
Tumor Necrosis Factor and Alzheimer's Disease: A Cause and Consequence Relationship
Sharma, V., Thakur, V. B. S., Singh, S. N., & Guleria, R. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120112064639 · Cited by 26
Šumanović-Glamuzina, D., Čulo, F., Čulo, M. I., Konjevoda, P., & Raguž, M. J. (2017) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2017.1381 · Cited by 26
Armstrong, R. C. (2007) · Future Neurology · doi:10.2217/14796708.2.6.689 · Cited by 27
Rodriguez, M., Zoecklein, L. J., Papke, L. M., Gamez, J. D., Đenić, A., Macura, S. I., & Howe, C. L. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00151.x · Cited by 26
Hepatic arginase deficiency fosters dysmyelination during postnatal CNS development
Liu, X.-B., Haney, J. R., Cantero, G., Lambert, J., Otero‐García, M., Truong, B., Gropman, A. L., Cobos, I., Cederbaum, S. D., & Lipshutz, G. S. (2019) · JCI Insight · doi:10.1172/jci.insight.130260 · Cited by 25
TNF‐α/TNFR2 Regulatory Axis Stimulates EphB2‐Mediated Neuroregeneration Via Activation of NF‐κB
Pozniak, P. D., Darbinyan, A., & Khalili, K. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25219 · Cited by 25
The promise of anti-inflammatory therapies for CNS injuries and diseases
Rivest, S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.64 · Cited by 26
Abdel-Maged, A. E.-S., Gad, A. M., Rashed, L. A., Azab, S. S., Mohamed, E. A., & Awad, A. S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01972-9 · Cited by 29
Arancibia-Cárcamo, C. V., Osawa, H., Arnett, H. A., Hašková, Z., George, A. J. T., Ono, S. J., Ting, J. P. ‐., & Streilein, J. W. (2004) · European Journal of Immunology · doi:10.1002/eji.200324195 · Cited by 25
Self-citationThe cancer stem cell: evidence for its origin as an injured autoreactive T cell.
Grandics, P. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-6 · Cited by 25
Stoolman, J. S., Grant, R. A., Poor, T. A., Weinberg, S. E., D’Alessandro, K. B., Tan, J., Hu, J. Y.-S., Zerrer, M. E., Wood, W. A., Harding, M. C., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01080-1 · Cited by 24
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation
Ossola, B., Zhao, C., Compston, A., Pluchino, S., Franklin, R. J. M., & Spillantini, M. G. (2015) · Glia · doi:10.1002/glia.22940 · Cited by 27
Tumor Necrosis Factor Receptor Superfamily in T Cell Priming and Effector Function
Muller, J., Baeyens, A., & Dustin, M. L. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.08.001 · Cited by 24
Raphael, I., Gomez‐Rivera, F., Raphael, R. A., Robinson, R. R., Nalawade, S. A., & Forsthuber, T. G. (2019) · JCI Insight · doi:10.1172/jci.insight.132527 · Cited by 24
Metadata
- Authors
- Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Ting, Jenny P.-Y.
- Venue
- Nature Neuroscience
- Published
- 2001-10-15
- Volume
- 4
- Issue
- 11
- Pages
- 1116-1122
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1509596990
- Cited by
- 1,012
- References
- 48
- Citations by year
- 2026: 26 · 2025: 30 · 2024: 37 · 2023: 39 · 2022: 40 · 2021: 43 · 2020: 46 · 2019: 43 · 2018: 34 · 2017: 40 · 2016: 36 · 2015: 45 · 2014: 46 · 2013: 45 · 2012: 51
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS34190, R01NS034190)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- TNF-α, remyelination, demyelination, oligodendrocyte progenitors, oligodendrocyte proliferation, TNF receptor 1, TNF receptor 2, cuprizone, oligodendrocyte precursor cells, demyelinating disease, central nervous system regeneration
- MeSH terms
- Animals, B-Lymphocytes, Brain Chemistry, Corpus Callosum, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Humans, Immunohistochemistry, Macrophages, Male, Monoamine Oxidase Inhibitors, Myelin Sheath, Oligodendroglia, Stem Cells, Tumor Necrosis Factor-alpha, Antigens, CD, Up-Regulation, Apoptosis, Microglia, Receptors, Tumor Necrosis Factor, Mice, Knockout, In Situ Nick-End Labeling, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
